{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:15:15Z","timestamp":1774044915852,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Treatment for neuromuscular hip dysplasia (NMHD) typically involves osteotomies of the proximal femur and\/or pelvis, and the potential for significant volume blood loss is high. Tranexamic acid (TXA) functions as an antifibinolytic and has been shown to reduce bleeding in many operative settings. Retrospective evidence for the use of TXA in children undergoing NMHD reconstruction is inconclusive, and to our knowledge, prospective evaluation has never been performed. The purpose of this study was to examine the effectiveness of TXA use on intra- and postoperative outcomes during bony reconstruction for NMHD. In this matched comparative study, a prospective cohort of patients undergoing bony reconstruction for NMHD who were given TXA was enrolled and then matched to a retrospective cohort who previously underwent the same surgery without administration of TXA. The primary outcome variable was a change in perioperative hemoglobin values from preoperative to 1 day postoperatively. Secondary objectives were percent loss of estimated blood volume, postoperative transfusion requirements, and length of hospital stay. Forty-eight patients, 24 in each cohort, were included in the analyses. Mean age at surgery was 7.09 years (\u00b12.5). Fifty percent of each cohort underwent bilateral varus derotational osteotomy with pelvic acetabuloplasty. No statistical differences were found in postoperative hemoglobin differences (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.18), length of hospital stay (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.45), or blood transfusion requirements (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.56) between cohorts. Intraoperative administration of TXA to patients undergoing bony reconstruction for NMHD was not found to reduce postoperative blood loss or requirement for blood transfusion. Future studies should employ a larger, prospective randomized controlled trial to verify these findings.<\/jats:p>","DOI":"10.1097\/bpb.0000000000001219","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T14:00:31Z","timestamp":1732888831000},"page":"315-319","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Does tranexamic acid reduce blood loss for children undergoing reconstruction for neuromuscular hip dysplasia? A matched comparative study"],"prefix":"10.1097","volume":"34","author":[{"given":"Lauren C.","family":"Hyer","sequence":"first","affiliation":[{"name":"Shriners Children\u2019s, Greenville, Greenville, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily R.","family":"Shull","sequence":"additional","affiliation":[{"name":"Shriners Children\u2019s, Greenville, Greenville, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Westberry","sequence":"additional","affiliation":[{"name":"Shriners Children\u2019s, Greenville, Greenville, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney A.","family":"Southerland","sequence":"additional","affiliation":[{"name":"Shriners Children\u2019s, Greenville, Greenville, South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Lew","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Center for Biostatistics and Data Science, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"R1-20250529","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1469-8749.2001.tb00241.x","article-title":"Hip dysplasia in bilateral cerebral palsy: incidence and natural history in children aged 18 months to 5 years.","volume":"43","author":"Scrutton","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"R2-20250529","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1302\/0301-620X.84B5.0840720","article-title":"Hip surveillance in children with cerebral palsy. Impact on the surgical management of spastic hip disease.","volume":"84","author":"Dobson","year":"2002","journal-title":"J Bone Joint Surg Br"},{"key":"R3-20250529","doi-asserted-by":"crossref","first-page":"760","DOI":"10.5435\/JAAOS-D-18-00184","article-title":"Hip surveillance in children with cerebral palsy.","volume":"27","author":"Shrader","year":"2019","journal-title":"J Am Acad Orthop Surg"},{"key":"R4-20250529","first-page":"121","article-title":"Hip displacement in cerebral palsy.","volume":"88","author":"Soo","year":"2006","journal-title":"J Bone Joint Surg Am"},{"issue":"Supplement 1 Suppl 1","key":"R5-20250529","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/BPO.0000000000001347","article-title":"Natural history of spastic hip disease.","volume":"39","author":"Lins","year":"2019","journal-title":"J Pediatr Orthop"},{"key":"R6-20250529","first-page":"171","article-title":"The development of Australian standards of care for hip surveillance in children with cerebral palsy: how did we reach consensus?","volume":"4","author":"Wynter","year":"2011","journal-title":"J Pediatr Rehabil Med"},{"key":"R7-20250529","doi-asserted-by":"crossref","first-page":"E310","DOI":"10.1097\/01.BRS.0000132513.88038.64","article-title":"Clotting parameters and thromboelastography in children with neuromuscular and idiopathic scoliosis undergoing posterior spinal fusion.","volume":"29","author":"Brenn","year":"2004","journal-title":"Spine (Phila Pa 1976)"},{"key":"R8-20250529","doi-asserted-by":"crossref","first-page":"E549","DOI":"10.1097\/BRS.0b013e31823d009b","article-title":"Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis?","volume":"37","author":"Dhawale","year":"2012","journal-title":"Spine (Phila Pa 1976)"},{"key":"R9-20250529","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/pan.12981","article-title":"Perioperative complications and outcomes in children with cerebral palsy undergoing scoliosis surgery.","volume":"26","author":"Bendon","year":"2016","journal-title":"Paediatr Anaesth"},{"key":"R10-20250529","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/BPO.0000000000000497","article-title":"What\u2019s new in the management of neuromuscular scoliosis.","volume":"36","author":"Brooks","year":"2016","journal-title":"J Pediatr Orthop"},{"key":"R11-20250529","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ACO.0000000000000728","article-title":"Tranexamic acid and perioperative bleeding in children: what do we still need to know?","volume":"32","author":"Goobie","year":"2019","journal-title":"Curr Opin Anaesthesiol"},{"key":"R12-20250529","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1213\/ANE.0000000000000080","article-title":"The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: a systematic review of the literature.","volume":"118","author":"Faraoni","year":"2014","journal-title":"Anesth Analg"},{"key":"R13-20250529","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.2106\/JBJS.18.00314","article-title":"Tranexamic acid is efficacious at decreasing the rate of blood loss in adolescent scoliosis surgery: a randomized placebo-controlled trial.","volume":"100","author":"Goobie","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R14-20250529","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jtcvs.2011.06.048","article-title":"Comparative analysis of antifibrinolytic medications in pediatric heart surgery.","volume":"143","author":"Pasquali","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R15-20250529","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.","volume":"389","author":"Shakur","year":"2017","journal-title":"Lancet"},{"key":"R16-20250529","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"R17-20250529","doi-asserted-by":"crossref","first-page":"e28506","DOI":"10.1097\/MD.0000000000028506","article-title":"Tranexamic acid use decreases transfusion rate in children with cerebral palsy undergoing proximal femoral varus derotational osteotomy.","volume":"101","author":"Compton","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"R18-20250529","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.1097\/BPO.0000000000001534","article-title":"The Use of Tranexamic Acid (TXA) in neuromuscular hip reconstruction: can we alter the need for blood transfusion?","volume":"40","author":"Lins","year":"2020","journal-title":"J Pediatr Orthop"},{"key":"R19-20250529","doi-asserted-by":"crossref","first-page":"827027","DOI":"10.1155\/2015\/827027","article-title":"The value of tranexamic acid in reducing blood loss following hip reconstruction in children with cerebral palsy.","volume":"2015","author":"Majid","year":"2015","journal-title":"J Blood Transfus"},{"key":"R20-20250529","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1302\/1863-2548.13.180143","article-title":"Impact of tranexamic acid use on blood loss and transfusion rates following femoral varus derotational osteotomy in children with cerebral palsy.","volume":"13","author":"Nazareth","year":"2019","journal-title":"J Child Orthop"},{"key":"R21-20250529","doi-asserted-by":"crossref","first-page":"101488","DOI":"10.1016\/j.jcot.2021.101488","article-title":"Efficacy of antifibrinolytics in reducing blood loss during hip reconstruction surgery in cerebral palsy children. A systematic review and meta-analysis.","volume":"20","author":"Rangasamy","year":"2021","journal-title":"J Clin Orthop Trauma"},{"key":"R22-20250529","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00590-020-02663-w","article-title":"Safety and efficacy of tranexamic acid in children with cerebral palsy undergoing femoral varus derotational osteotomy: a double cohort study.","volume":"30","author":"Tzatzairis","year":"2020","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"R25-20250529","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/18632521231199518","article-title":"Effect of tranexamic acid on intraoperative blood loss in pediatric osteotomies around the hip: study protocol for a double-blind randomized placebo-controlled trial.","volume":"17","author":"van Kouswijk","year":"2023","journal-title":"J Child Orthop"}],"container-title":["Journal of Pediatric Orthopaedics B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BPB.0000000000001219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T11:00:24Z","timestamp":1748516424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BPB.0000000000001219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bpb.0000000000001219","relation":{},"ISSN":["1060-152X","1473-5865"],"issn-type":[{"value":"1060-152X","type":"print"},{"value":"1473-5865","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}